Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 1;153(1):245-255.
doi: 10.1097/PRS.0000000000010591. Epub 2023 Apr 25.

Commercial Insurance Rates and Coding for Lymphedema Procedures: The Current State of Confusion and Need for Consensus

Affiliations

Commercial Insurance Rates and Coding for Lymphedema Procedures: The Current State of Confusion and Need for Consensus

Danielle H Rochlin et al. Plast Reconstr Surg. .

Abstract

Background: Surgical treatment of lymphedema has outpaced coding paradigms. In the setting of ambiguity regarding coding for physiologic procedures [lymphovenous bypass (LVB) and vascularized lymph node transplant (VLNT)], we hypothesized that there would be variation in commercial reimbursement based on coding pattern.

Methods: The authors performed a cross-sectional analysis of 2021 nationwide hospital pricing data for 21 CPT codes encompassing excisional (direct excision, liposuction), physiologic (LVB, VLNT), and ancillary (lymphangiography) procedures. Within-hospital ratios (WHRs) and across-hospital ratios (AHRs) for adjusted commercial rates per CPT code quantified price variation. Mixed effects linear regression modeled associations of commercial rate with public payer (Medicare and Medicaid), self-pay, and chargemaster rates.

Results: A total of 270,254 commercial rates, including 95,774 rates for physiologic procedures, were extracted from 2863 hospitals. Lymphangiography codes varied most in commercial price (WHR, 1.76 to 3.89; AHR, 8.12 to 44.38). For physiologic codes, WHRs ranged from 1.01 (VLNT; free omental flap) to 3.03 (LVB; unlisted lymphatic procedure), and AHRs ranged from 5.23 (LVB; lymphatic channel incision) to 10.36 (LVB; unlisted lymphatic procedure). Median adjusted commercial rates for excisional procedures ($3635.84) were higher than for physiologic procedures ($2560.40; P < 0.001). Commercial rate positively correlated with Medicare rate for all physiologic codes combined, although regression coefficients varied by code.

Conclusions: Commercial payer-negotiated rates for physiologic procedures were highly variable both within and across hospitals, reflective of variation in CPT codes. Physiologic procedures may be undervalued relative to excisional procedures. Consistent coding nomenclature should be developed for physiologic and ancillary procedures.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Within- and across-hospital variation in GAF-adjusted commercial rate per CPT code for (A) excisional, (B) physiologic, and (C) ancillary procedures.
AHR, across-hospital ratio. LVB, lymphovenous bypass. VLNT, vascularized lymph node transplant. WHR, within-hospital ratio. WHR plots exclude outliers. Note difference in x-axis scale for lymphangiography plots. Red dashed lines separate procedure groups.
Figure 1.
Figure 1.. Within- and across-hospital variation in GAF-adjusted commercial rate per CPT code for (A) excisional, (B) physiologic, and (C) ancillary procedures.
AHR, across-hospital ratio. LVB, lymphovenous bypass. VLNT, vascularized lymph node transplant. WHR, within-hospital ratio. WHR plots exclude outliers. Note difference in x-axis scale for lymphangiography plots. Red dashed lines separate procedure groups.
Figure 1.
Figure 1.. Within- and across-hospital variation in GAF-adjusted commercial rate per CPT code for (A) excisional, (B) physiologic, and (C) ancillary procedures.
AHR, across-hospital ratio. LVB, lymphovenous bypass. VLNT, vascularized lymph node transplant. WHR, within-hospital ratio. WHR plots exclude outliers. Note difference in x-axis scale for lymphangiography plots. Red dashed lines separate procedure groups.
Figure 2.
Figure 2.. Comparative kernel density distributions of GAF-normalized commercial rates for physiologic lymphedema procedures in comparison to (A) excisional lymphedema procedures and (B) breast reconstructive procedures.
LVB, lymphovenous bypass. VLNT, vascularized lymph node transplant. Breast procedures correspond to the following CPT codes: insertion of tissue expander (CPT 19357), breast reconstruction with free flap (19364), and breast reduction (19318).
Figure 2.
Figure 2.. Comparative kernel density distributions of GAF-normalized commercial rates for physiologic lymphedema procedures in comparison to (A) excisional lymphedema procedures and (B) breast reconstructive procedures.
LVB, lymphovenous bypass. VLNT, vascularized lymph node transplant. Breast procedures correspond to the following CPT codes: insertion of tissue expander (CPT 19357), breast reconstruction with free flap (19364), and breast reduction (19318).
Figure 3.
Figure 3.. Comparison among GAF-adjusted rates per CPT code for excisional and physiologic procedures.
LVB, lymphovenous bypass. VLNT, vascularized lymph node transplant. All rates except for Medicare are normalized based on the Geographic Adjustment Factor (GAF). Red dashed lines separate procedure groups.
Figure 4.
Figure 4.. Relationship between commercial and Medicare rates for physiologic procedures.
Graphed values are between 5th and 95th percentiles for respective rates. Slope of line approximates coefficient from simple linear regression of commercial rate as a function of Medicare rate: 0.75 (95% CI 0.71 – 0.80, p<0.001).

Similar articles

Cited by

References

    1. Charles H Elephantiasis of the Leg. In: Latham A, English T, eds. A System of Treatment. Vol 3. Churchill; 1912.
    1. Sistrunk W Modification of the Operation for Elephantiasis. JAMA. 1918;71:800–803.
    1. Schaverien MV, Dayan JH. Key Topic: Patient Selection and Evidence-Based Algorithmic Approach to Surgical Management of Lymphedema. In: Schaverien MV, Dayan JH, eds. Multimodal Management of Upper and Lower Extremity Lymphedema. Springer International Publishing; 2022:47–52.
    1. Brorson H Liposuction in Arm Lymphedema Treatment. Scand J Surg. 2003;92(4):287–295. - PubMed
    1. Chang DW, Dayan J, Greene AK, et al. Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference. Plastic & Reconstructive Surgery. 2021;147(4):975–993. - PubMed

Publication types